Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Utrecht Centre for Affordable Biotherapeutics (UCAB) is a non-profit foundation dedicated to increasing the global accessibility of high-quality biopharmaceuticals. Established by Utrecht University, UCAB focuses on developing biosimilar versions of essential monoclonal antibodies and transferring the production technology to manufacturers in low- and middle-income countries. By facilitating local production and providing technical expertise, the organization aims to significantly reduce the cost of life-saving treatments for diseases such as cancer and autoimmune disorders. UCAB's collaborative model involves partnerships with international health organizations and regional pharmaceutical companies to ensure sustainable supply chains in underserved markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Utrecht Centre for Affordable Biotherapeutics.